– Reuters
Despite Early Approval Of Omidubicel, Analyst Says Longer-Term Financial Overhang Remains For Gamida Cell
On Monday, Gamida Cell Ltd (NASDAQ:GMDA) received Omidubicel approval two weeks before the PDUFA date of 1 May. Soon after, Gamida…